NCT05338047
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Hospital Universitario Dr. José Eleuterio González Monterrey, Nuevo León, Mexico
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,099 public trials
2,041 recruiting studies
Lymphoproliferative Disorders trial results
NCT03320070
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
- Locations
-
- UAB Lung Health Center Birmingham, Alabama, United States
- David Geffen School of Medicine Los Angeles, California, United States
- National Jewish Health Denver, Colorado, United States
- University of Florida Division of Pulmonary, Critical Care, and Sleep Medicine Gainesville, Florida, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- City of Hope - Duarte Duarte, California, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Mount Sinai Hospital-The Donald H. Ruttenberg Cancer Treatment Center New York, United States
- Weill Cornell Medical Center, Div. of Hematology Medical Oncology New York, United States
NCT05571787
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- PPD Austin Austin, Texas, United States
NCT01090089
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Universitätsklinikum Münster Münster, North Rhein Westfallen, Germany
- Universitätsklinikum Aachen Aachen, Germany
- Agirov Klinik Berg, Germany
- HELIOS Klinikum Berlin-Buch Berlin, Germany
NCT03385681
- Conditions
- Agnosia, Hematologic Diseases, Hemic and Lymphatic Diseases, +21 more
- Locations
-
- Haukeland University Hospital Bergen, Norway
- Akershus University hospital Lillestrøm, Norway
- Oslo University Hospital Oslo, Norway
- Stavanger University Hospital Stavanger, Norway
Completed
Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma
NCT02278315
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Loyola University Medical Center Maywood, Illinois, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
NCT01938001
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Mitchell Cancer Center, University of South Alabama Mobile, Alabama, United States
- Arizona Center for Cancer Care Glendale, Arizona, United States
- Southwest Cancer Care Medical Group Escondido, California, United States
- Marin Oncology Associates Greenbrae, California, United States
- Conditions
- Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +15 more
- Locations
-
- Hospital Italiano La Plata /ID# 150812 La Plata, Buenos Aires, Argentina
- Fundaleu /Id# 150811 Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
- Cemic /Id# 150810 Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
- Sanatorio Allende /ID# 150813 Córdoba, Argentina
Completed
Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT01066663
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States